nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolterodine—CYP2C9—Leflunomide—systemic scleroderma	0.118	0.338	CbGbCtD
Tolterodine—CYP2D6—Captopril—systemic scleroderma	0.085	0.243	CbGbCtD
Tolterodine—CYP2C19—Prednisone—systemic scleroderma	0.0704	0.201	CbGbCtD
Tolterodine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0426	0.121	CbGbCtD
Tolterodine—CYP3A4—Prednisone—systemic scleroderma	0.034	0.0971	CbGbCtD
Tolterodine—Angioedema—Pentoxifylline—systemic scleroderma	0.00372	0.00572	CcSEcCtD
Tolterodine—Palpitations—Pentoxifylline—systemic scleroderma	0.0036	0.00553	CcSEcCtD
Tolterodine—Hallucination—Captopril—systemic scleroderma	0.00352	0.00543	CcSEcCtD
Tolterodine—Bronchitis—Leflunomide—systemic scleroderma	0.00351	0.0054	CcSEcCtD
Tolterodine—Chest pain—Pentoxifylline—systemic scleroderma	0.00346	0.00533	CcSEcCtD
Tolterodine—Anxiety—Pentoxifylline—systemic scleroderma	0.00345	0.00531	CcSEcCtD
Tolterodine—Dysuria—Leflunomide—systemic scleroderma	0.00341	0.00525	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Leflunomide—systemic scleroderma	0.00339	0.00522	CcSEcCtD
Tolterodine—Dry mouth—Pentoxifylline—systemic scleroderma	0.00339	0.00521	CcSEcCtD
Tolterodine—Confusional state—Pentoxifylline—systemic scleroderma	0.00335	0.00515	CcSEcCtD
Tolterodine—Bronchitis—Mycophenolic acid—systemic scleroderma	0.00335	0.00515	CcSEcCtD
Tolterodine—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.00332	0.00511	CcSEcCtD
Tolterodine—Oedema—Pentoxifylline—systemic scleroderma	0.00332	0.00511	CcSEcCtD
Tolterodine—Infection—Pentoxifylline—systemic scleroderma	0.0033	0.00508	CcSEcCtD
Tolterodine—Flushing—Captopril—systemic scleroderma	0.00329	0.00506	CcSEcCtD
Tolterodine—Dysuria—Mycophenolic acid—systemic scleroderma	0.00325	0.00501	CcSEcCtD
Tolterodine—Tachycardia—Pentoxifylline—systemic scleroderma	0.00324	0.00499	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Mycophenolic acid—systemic scleroderma	0.00323	0.00498	CcSEcCtD
Tolterodine—Angioedema—Mometasone—systemic scleroderma	0.00321	0.00494	CcSEcCtD
Tolterodine—Weight increased—Mycophenolic acid—systemic scleroderma	0.00317	0.00487	CcSEcCtD
Tolterodine—Urinary tract infection—Leflunomide—systemic scleroderma	0.00316	0.00487	CcSEcCtD
Tolterodine—Sinusitis—Leflunomide—systemic scleroderma	0.00305	0.0047	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Pentoxifylline—systemic scleroderma	0.00302	0.00466	CcSEcCtD
Tolterodine—Urinary retention—Mycophenolate mofetil—systemic scleroderma	0.00302	0.00465	CcSEcCtD
Tolterodine—Urinary tract infection—Mycophenolic acid—systemic scleroderma	0.00302	0.00464	CcSEcCtD
Tolterodine—Bronchitis—Lisinopril—systemic scleroderma	0.00301	0.00464	CcSEcCtD
Tolterodine—Chest pain—Mometasone—systemic scleroderma	0.00299	0.0046	CcSEcCtD
Tolterodine—Arthralgia—Mometasone—systemic scleroderma	0.00299	0.0046	CcSEcCtD
Tolterodine—Somnolence—Pentoxifylline—systemic scleroderma	0.00295	0.00454	CcSEcCtD
Tolterodine—Dysuria—Lisinopril—systemic scleroderma	0.00293	0.00451	CcSEcCtD
Tolterodine—Dry mouth—Mometasone—systemic scleroderma	0.00292	0.0045	CcSEcCtD
Tolterodine—Dyspepsia—Pentoxifylline—systemic scleroderma	0.00292	0.0045	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Lisinopril—systemic scleroderma	0.00291	0.00448	CcSEcCtD
Tolterodine—Sinusitis—Mycophenolic acid—systemic scleroderma	0.00291	0.00448	CcSEcCtD
Tolterodine—Oedema peripheral—Leflunomide—systemic scleroderma	0.00288	0.00443	CcSEcCtD
Tolterodine—Anaphylactic shock—Mometasone—systemic scleroderma	0.00286	0.00441	CcSEcCtD
Tolterodine—Weight increased—Lisinopril—systemic scleroderma	0.00285	0.00439	CcSEcCtD
Tolterodine—Infection—Mometasone—systemic scleroderma	0.00285	0.00438	CcSEcCtD
Tolterodine—Constipation—Pentoxifylline—systemic scleroderma	0.00284	0.00437	CcSEcCtD
Tolterodine—Angioedema—Captopril—systemic scleroderma	0.00282	0.00434	CcSEcCtD
Tolterodine—Hallucination—Mycophenolic acid—systemic scleroderma	0.00277	0.00427	CcSEcCtD
Tolterodine—Oedema peripheral—Mycophenolic acid—systemic scleroderma	0.00274	0.00422	CcSEcCtD
Tolterodine—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.00274	0.00421	CcSEcCtD
Tolterodine—Palpitations—Captopril—systemic scleroderma	0.00272	0.00419	CcSEcCtD
Tolterodine—Urinary tract infection—Lisinopril—systemic scleroderma	0.00272	0.00418	CcSEcCtD
Tolterodine—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.00271	0.00418	CcSEcCtD
Tolterodine—Visual impairment—Mycophenolic acid—systemic scleroderma	0.00268	0.00413	CcSEcCtD
Tolterodine—Bronchitis—Mycophenolate mofetil—systemic scleroderma	0.00264	0.00407	CcSEcCtD
Tolterodine—Arthralgia—Captopril—systemic scleroderma	0.00262	0.00404	CcSEcCtD
Tolterodine—Chest pain—Captopril—systemic scleroderma	0.00262	0.00404	CcSEcCtD
Tolterodine—Abdominal pain—Pentoxifylline—systemic scleroderma	0.00262	0.00404	CcSEcCtD
Tolterodine—Sinusitis—Lisinopril—systemic scleroderma	0.00262	0.00404	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Mometasone—systemic scleroderma	0.00261	0.00402	CcSEcCtD
Tolterodine—Dysuria—Mycophenolate mofetil—systemic scleroderma	0.00257	0.00395	CcSEcCtD
Tolterodine—Dry mouth—Captopril—systemic scleroderma	0.00257	0.00395	CcSEcCtD
Tolterodine—Confusional state—Captopril—systemic scleroderma	0.00254	0.00391	CcSEcCtD
Tolterodine—Dyspepsia—Mometasone—systemic scleroderma	0.00252	0.00388	CcSEcCtD
Tolterodine—Anaphylactic shock—Captopril—systemic scleroderma	0.00252	0.00387	CcSEcCtD
Tolterodine—Flatulence—Leflunomide—systemic scleroderma	0.0025	0.00385	CcSEcCtD
Tolterodine—Weight increased—Mycophenolate mofetil—systemic scleroderma	0.0025	0.00385	CcSEcCtD
Tolterodine—Hallucination—Lisinopril—systemic scleroderma	0.0025	0.00384	CcSEcCtD
Tolterodine—Oedema peripheral—Lisinopril—systemic scleroderma	0.00247	0.0038	CcSEcCtD
Tolterodine—Fatigue—Mometasone—systemic scleroderma	0.00247	0.0038	CcSEcCtD
Tolterodine—Tachycardia—Captopril—systemic scleroderma	0.00246	0.00378	CcSEcCtD
Tolterodine—Pain—Mometasone—systemic scleroderma	0.00245	0.00377	CcSEcCtD
Tolterodine—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00245	0.00377	CcSEcCtD
Tolterodine—Flatulence—Mycophenolic acid—systemic scleroderma	0.00239	0.00368	CcSEcCtD
Tolterodine—Asthenia—Pentoxifylline—systemic scleroderma	0.00238	0.00367	CcSEcCtD
Tolterodine—Urinary tract infection—Mycophenolate mofetil—systemic scleroderma	0.00238	0.00366	CcSEcCtD
Tolterodine—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00234	0.00361	CcSEcCtD
Tolterodine—Flushing—Lisinopril—systemic scleroderma	0.00233	0.00358	CcSEcCtD
Tolterodine—Angioedema—Leflunomide—systemic scleroderma	0.00232	0.00357	CcSEcCtD
Tolterodine—Sinusitis—Mycophenolate mofetil—systemic scleroderma	0.0023	0.00354	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.00229	0.00353	CcSEcCtD
Tolterodine—Arthralgia—Azathioprine—systemic scleroderma	0.00229	0.00353	CcSEcCtD
Tolterodine—Vertigo—Leflunomide—systemic scleroderma	0.00228	0.00351	CcSEcCtD
Tolterodine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00227	0.0035	CcSEcCtD
Tolterodine—Abdominal pain—Mometasone—systemic scleroderma	0.00226	0.00349	CcSEcCtD
Tolterodine—Palpitations—Leflunomide—systemic scleroderma	0.00225	0.00346	CcSEcCtD
Tolterodine—Somnolence—Captopril—systemic scleroderma	0.00224	0.00344	CcSEcCtD
Tolterodine—Dyspepsia—Captopril—systemic scleroderma	0.00221	0.00341	CcSEcCtD
Tolterodine—Dizziness—Pentoxifylline—systemic scleroderma	0.0022	0.00338	CcSEcCtD
Tolterodine—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.00219	0.00337	CcSEcCtD
Tolterodine—Infection—Azathioprine—systemic scleroderma	0.00218	0.00336	CcSEcCtD
Tolterodine—Vertigo—Mycophenolic acid—systemic scleroderma	0.00218	0.00335	CcSEcCtD
Tolterodine—Fatigue—Captopril—systemic scleroderma	0.00217	0.00334	CcSEcCtD
Tolterodine—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.00216	0.00333	CcSEcCtD
Tolterodine—Chest pain—Leflunomide—systemic scleroderma	0.00216	0.00333	CcSEcCtD
Tolterodine—Arthralgia—Leflunomide—systemic scleroderma	0.00216	0.00333	CcSEcCtD
Tolterodine—Anxiety—Leflunomide—systemic scleroderma	0.00216	0.00332	CcSEcCtD
Tolterodine—Constipation—Captopril—systemic scleroderma	0.00215	0.00331	CcSEcCtD
Tolterodine—Flatulence—Lisinopril—systemic scleroderma	0.00215	0.00331	CcSEcCtD
Tolterodine—Palpitations—Mycophenolic acid—systemic scleroderma	0.00214	0.0033	CcSEcCtD
Tolterodine—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.00212	0.00326	CcSEcCtD
Tolterodine—Dry mouth—Leflunomide—systemic scleroderma	0.00212	0.00326	CcSEcCtD
Tolterodine—Headache—Pentoxifylline—systemic scleroderma	0.00208	0.0032	CcSEcCtD
Tolterodine—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00207	0.00319	CcSEcCtD
Tolterodine—Feeling abnormal—Captopril—systemic scleroderma	0.00207	0.00319	CcSEcCtD
Tolterodine—Chest pain—Mycophenolic acid—systemic scleroderma	0.00206	0.00318	CcSEcCtD
Tolterodine—Arthralgia—Mycophenolic acid—systemic scleroderma	0.00206	0.00318	CcSEcCtD
Tolterodine—Infection—Leflunomide—systemic scleroderma	0.00206	0.00317	CcSEcCtD
Tolterodine—Gastrointestinal pain—Captopril—systemic scleroderma	0.00206	0.00317	CcSEcCtD
Tolterodine—Anxiety—Mycophenolic acid—systemic scleroderma	0.00206	0.00317	CcSEcCtD
Tolterodine—Asthenia—Mometasone—systemic scleroderma	0.00206	0.00316	CcSEcCtD
Tolterodine—Tachycardia—Leflunomide—systemic scleroderma	0.00202	0.00312	CcSEcCtD
Tolterodine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00202	0.00311	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.002	0.00308	CcSEcCtD
Tolterodine—Angioedema—Lisinopril—systemic scleroderma	0.002	0.00307	CcSEcCtD
Tolterodine—Confusional state—Mycophenolic acid—systemic scleroderma	0.00199	0.00307	CcSEcCtD
Tolterodine—Abdominal pain—Captopril—systemic scleroderma	0.00199	0.00306	CcSEcCtD
Tolterodine—Oedema—Mycophenolic acid—systemic scleroderma	0.00198	0.00305	CcSEcCtD
Tolterodine—Dry skin—Prednisone—systemic scleroderma	0.00197	0.00304	CcSEcCtD
Tolterodine—Infection—Mycophenolic acid—systemic scleroderma	0.00197	0.00303	CcSEcCtD
Tolterodine—Vertigo—Lisinopril—systemic scleroderma	0.00196	0.00302	CcSEcCtD
Tolterodine—Diarrhoea—Mometasone—systemic scleroderma	0.00196	0.00302	CcSEcCtD
Tolterodine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00193	0.00297	CcSEcCtD
Tolterodine—Palpitations—Lisinopril—systemic scleroderma	0.00193	0.00297	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00189	0.00291	CcSEcCtD
Tolterodine—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.00189	0.0029	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.00186	0.00286	CcSEcCtD
Tolterodine—Chest pain—Lisinopril—systemic scleroderma	0.00186	0.00286	CcSEcCtD
Tolterodine—Arthralgia—Lisinopril—systemic scleroderma	0.00186	0.00286	CcSEcCtD
Tolterodine—Anxiety—Lisinopril—systemic scleroderma	0.00185	0.00285	CcSEcCtD
Tolterodine—Dyspepsia—Leflunomide—systemic scleroderma	0.00183	0.00281	CcSEcCtD
Tolterodine—Dry mouth—Lisinopril—systemic scleroderma	0.00182	0.0028	CcSEcCtD
Tolterodine—Feeling abnormal—Azathioprine—systemic scleroderma	0.00181	0.00279	CcSEcCtD
Tolterodine—Asthenia—Captopril—systemic scleroderma	0.00181	0.00278	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.0018	0.00277	CcSEcCtD
Tolterodine—Confusional state—Lisinopril—systemic scleroderma	0.0018	0.00277	CcSEcCtD
Tolterodine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.0018	0.00276	CcSEcCtD
Tolterodine—Headache—Mometasone—systemic scleroderma	0.00179	0.00276	CcSEcCtD
Tolterodine—Fatigue—Leflunomide—systemic scleroderma	0.00179	0.00275	CcSEcCtD
Tolterodine—Oedema—Lisinopril—systemic scleroderma	0.00178	0.00274	CcSEcCtD
Tolterodine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00178	0.00274	CcSEcCtD
Tolterodine—Pain—Leflunomide—systemic scleroderma	0.00177	0.00273	CcSEcCtD
Tolterodine—Constipation—Leflunomide—systemic scleroderma	0.00177	0.00273	CcSEcCtD
Tolterodine—Infection—Lisinopril—systemic scleroderma	0.00177	0.00273	CcSEcCtD
Tolterodine—Somnolence—Mycophenolic acid—systemic scleroderma	0.00176	0.00271	CcSEcCtD
Tolterodine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00175	0.00269	CcSEcCtD
Tolterodine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00174	0.00268	CcSEcCtD
Tolterodine—Tachycardia—Lisinopril—systemic scleroderma	0.00174	0.00268	CcSEcCtD
Tolterodine—Abdominal pain—Azathioprine—systemic scleroderma	0.00174	0.00267	CcSEcCtD
Tolterodine—Diarrhoea—Captopril—systemic scleroderma	0.00172	0.00265	CcSEcCtD
Tolterodine—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00172	0.00265	CcSEcCtD
Tolterodine—Feeling abnormal—Leflunomide—systemic scleroderma	0.00171	0.00263	CcSEcCtD
Tolterodine—Fatigue—Mycophenolic acid—systemic scleroderma	0.00171	0.00263	CcSEcCtD
Tolterodine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.0017	0.00261	CcSEcCtD
Tolterodine—Weight increased—Prednisone—systemic scleroderma	0.00169	0.00261	CcSEcCtD
Tolterodine—Pain—Mycophenolic acid—systemic scleroderma	0.00169	0.0026	CcSEcCtD
Tolterodine—Constipation—Mycophenolic acid—systemic scleroderma	0.00169	0.0026	CcSEcCtD
Tolterodine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00169	0.0026	CcSEcCtD
Tolterodine—Dizziness—Captopril—systemic scleroderma	0.00166	0.00256	CcSEcCtD
Tolterodine—Abdominal pain—Leflunomide—systemic scleroderma	0.00164	0.00252	CcSEcCtD
Tolterodine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00163	0.00251	CcSEcCtD
Tolterodine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00163	0.00251	CcSEcCtD
Tolterodine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00163	0.00251	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00162	0.0025	CcSEcCtD
Tolterodine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00162	0.0025	CcSEcCtD
Tolterodine—Hypersensitivity—Azathioprine—systemic scleroderma	0.00162	0.00249	CcSEcCtD
Tolterodine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00162	0.00249	CcSEcCtD
Tolterodine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00159	0.00245	CcSEcCtD
Tolterodine—Somnolence—Lisinopril—systemic scleroderma	0.00158	0.00244	CcSEcCtD
Tolterodine—Headache—Captopril—systemic scleroderma	0.00158	0.00243	CcSEcCtD
Tolterodine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00157	0.00242	CcSEcCtD
Tolterodine—Dyspepsia—Lisinopril—systemic scleroderma	0.00157	0.00241	CcSEcCtD
Tolterodine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00156	0.00241	CcSEcCtD
Tolterodine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00156	0.0024	CcSEcCtD
Tolterodine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00156	0.0024	CcSEcCtD
Tolterodine—Infection—Mycophenolate mofetil—systemic scleroderma	0.00155	0.00239	CcSEcCtD
Tolterodine—Fatigue—Lisinopril—systemic scleroderma	0.00154	0.00237	CcSEcCtD
Tolterodine—Hypersensitivity—Leflunomide—systemic scleroderma	0.00153	0.00235	CcSEcCtD
Tolterodine—Pain—Lisinopril—systemic scleroderma	0.00152	0.00235	CcSEcCtD
Tolterodine—Constipation—Lisinopril—systemic scleroderma	0.00152	0.00235	CcSEcCtD
Tolterodine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00152	0.00235	CcSEcCtD
Tolterodine—Diarrhoea—Azathioprine—systemic scleroderma	0.0015	0.00231	CcSEcCtD
Tolterodine—Asthenia—Leflunomide—systemic scleroderma	0.00149	0.00229	CcSEcCtD
Tolterodine—Hallucination—Prednisone—systemic scleroderma	0.00148	0.00228	CcSEcCtD
Tolterodine—Feeling abnormal—Lisinopril—systemic scleroderma	0.00147	0.00226	CcSEcCtD
Tolterodine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00146	0.00224	CcSEcCtD
Tolterodine—Dysuria—Methotrexate—systemic scleroderma	0.00145	0.00224	CcSEcCtD
Tolterodine—Dizziness—Azathioprine—systemic scleroderma	0.00145	0.00224	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.00145	0.00223	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00142	0.00219	CcSEcCtD
Tolterodine—Asthenia—Mycophenolic acid—systemic scleroderma	0.00142	0.00219	CcSEcCtD
Tolterodine—Diarrhoea—Leflunomide—systemic scleroderma	0.00142	0.00218	CcSEcCtD
Tolterodine—Abdominal pain—Lisinopril—systemic scleroderma	0.00141	0.00217	CcSEcCtD
Tolterodine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00139	0.00214	CcSEcCtD
Tolterodine—Flushing—Prednisone—systemic scleroderma	0.00138	0.00213	CcSEcCtD
Tolterodine—Headache—Azathioprine—systemic scleroderma	0.00138	0.00212	CcSEcCtD
Tolterodine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00137	0.00212	CcSEcCtD
Tolterodine—Dizziness—Leflunomide—systemic scleroderma	0.00137	0.00211	CcSEcCtD
Tolterodine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00135	0.00208	CcSEcCtD
Tolterodine—Pain—Mycophenolate mofetil—systemic scleroderma	0.00134	0.00206	CcSEcCtD
Tolterodine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00134	0.00206	CcSEcCtD
Tolterodine—Hypersensitivity—Lisinopril—systemic scleroderma	0.00131	0.00202	CcSEcCtD
Tolterodine—Dizziness—Mycophenolic acid—systemic scleroderma	0.00131	0.00201	CcSEcCtD
Tolterodine—Headache—Leflunomide—systemic scleroderma	0.0013	0.002	CcSEcCtD
Tolterodine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00129	0.00198	CcSEcCtD
Tolterodine—Asthenia—Lisinopril—systemic scleroderma	0.00128	0.00197	CcSEcCtD
Tolterodine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00128	0.00197	CcSEcCtD
Tolterodine—Headache—Mycophenolic acid—systemic scleroderma	0.00124	0.00191	CcSEcCtD
Tolterodine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00123	0.0019	CcSEcCtD
Tolterodine—Diarrhoea—Lisinopril—systemic scleroderma	0.00122	0.00188	CcSEcCtD
Tolterodine—Visual impairment—Methotrexate—systemic scleroderma	0.0012	0.00185	CcSEcCtD
Tolterodine—Angioedema—Prednisone—systemic scleroderma	0.00118	0.00182	CcSEcCtD
Tolterodine—Dizziness—Lisinopril—systemic scleroderma	0.00118	0.00181	CcSEcCtD
Tolterodine—Vertigo—Prednisone—systemic scleroderma	0.00117	0.00179	CcSEcCtD
Tolterodine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00115	0.00177	CcSEcCtD
Tolterodine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00172	CcSEcCtD
Tolterodine—Headache—Lisinopril—systemic scleroderma	0.00112	0.00172	CcSEcCtD
Tolterodine—Arthralgia—Prednisone—systemic scleroderma	0.0011	0.0017	CcSEcCtD
Tolterodine—Anxiety—Prednisone—systemic scleroderma	0.0011	0.00169	CcSEcCtD
Tolterodine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00164	CcSEcCtD
Tolterodine—Anaphylactic shock—Prednisone—systemic scleroderma	0.00106	0.00163	CcSEcCtD
Tolterodine—Oedema—Prednisone—systemic scleroderma	0.00106	0.00163	CcSEcCtD
Tolterodine—Infection—Prednisone—systemic scleroderma	0.00105	0.00162	CcSEcCtD
Tolterodine—Tachycardia—Prednisone—systemic scleroderma	0.00103	0.00159	CcSEcCtD
Tolterodine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00159	CcSEcCtD
Tolterodine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000978	0.00151	CcSEcCtD
Tolterodine—Vertigo—Methotrexate—systemic scleroderma	0.000974	0.0015	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000964	0.00148	CcSEcCtD
Tolterodine—Dyspepsia—Prednisone—systemic scleroderma	0.000932	0.00143	CcSEcCtD
Tolterodine—Chest pain—Methotrexate—systemic scleroderma	0.000923	0.00142	CcSEcCtD
Tolterodine—Arthralgia—Methotrexate—systemic scleroderma	0.000923	0.00142	CcSEcCtD
Tolterodine—Fatigue—Prednisone—systemic scleroderma	0.000912	0.0014	CcSEcCtD
Tolterodine—Constipation—Prednisone—systemic scleroderma	0.000905	0.00139	CcSEcCtD
Tolterodine—Confusional state—Methotrexate—systemic scleroderma	0.000892	0.00137	CcSEcCtD
Tolterodine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000884	0.00136	CcSEcCtD
Tolterodine—Infection—Methotrexate—systemic scleroderma	0.000879	0.00135	CcSEcCtD
Tolterodine—Feeling abnormal—Prednisone—systemic scleroderma	0.000872	0.00134	CcSEcCtD
Tolterodine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000865	0.00133	CcSEcCtD
Tolterodine—Abdominal pain—Prednisone—systemic scleroderma	0.000837	0.00129	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000806	0.00124	CcSEcCtD
Tolterodine—Somnolence—Methotrexate—systemic scleroderma	0.000786	0.00121	CcSEcCtD
Tolterodine—Hypersensitivity—Prednisone—systemic scleroderma	0.00078	0.0012	CcSEcCtD
Tolterodine—Dyspepsia—Methotrexate—systemic scleroderma	0.000779	0.0012	CcSEcCtD
Tolterodine—Fatigue—Methotrexate—systemic scleroderma	0.000763	0.00117	CcSEcCtD
Tolterodine—Asthenia—Prednisone—systemic scleroderma	0.000759	0.00117	CcSEcCtD
Tolterodine—Pain—Methotrexate—systemic scleroderma	0.000756	0.00116	CcSEcCtD
Tolterodine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000729	0.00112	CcSEcCtD
Tolterodine—Diarrhoea—Prednisone—systemic scleroderma	0.000724	0.00111	CcSEcCtD
Tolterodine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000723	0.00111	CcSEcCtD
Tolterodine—Dizziness—Prednisone—systemic scleroderma	0.0007	0.00108	CcSEcCtD
Tolterodine—Abdominal pain—Methotrexate—systemic scleroderma	0.000699	0.00108	CcSEcCtD
Tolterodine—Headache—Prednisone—systemic scleroderma	0.000663	0.00102	CcSEcCtD
Tolterodine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000652	0.001	CcSEcCtD
Tolterodine—Asthenia—Methotrexate—systemic scleroderma	0.000635	0.000977	CcSEcCtD
Tolterodine—Diarrhoea—Methotrexate—systemic scleroderma	0.000605	0.000932	CcSEcCtD
Tolterodine—Dizziness—Methotrexate—systemic scleroderma	0.000585	0.0009	CcSEcCtD
Tolterodine—Headache—Methotrexate—systemic scleroderma	0.000554	0.000853	CcSEcCtD
